Lucid Diagnostics redeems 2023 convertible note, issues $1.00/sh 12% secured notes due 2029

Lucid Diagnostics Inc.

Notice to redeem 2023 Senior Convertible Note at optional redemption price; payment due within 10-20 business days.
Enters Securities Purchase Agreement for 2024 Senior Secured Convertible Notes with 12% annual interest, 5-year maturity.
Notes convertible at $1.00/share; secured by all company assets; financial covenant requires minimum $5M cash.
Event of default if no positive Medicare coverage decision for EsoGuard by 18-month anniversary of issuance.
PAVmed agrees not to sell LUCD shares for six months from closing.

item 1.01 item 1.02 item 2.03 item 3.02 item 3.03 item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.